Schering Sues Orchid In Latest Clarinex Patent Suit

Law360, New York (December 15, 2008, 12:00 AM EST) -- Schering Corp. has targeted Orchid Chemicals and Pharmaceuticals Ltd. and a subsidiary, Orgenus Pharma Inc., in the latest infringement suit over a patent for a tablet version of the blockbuster allergy medication Clarinex.

Schering filed suit Friday in the U.S. District Court for the District of New Jersey, accusing the Indian generics maker of infringing U.S. Patent Number 7,405,223, a method patent for “treating allergic and inflammatory conditions,” according to the patent application.

Orchid violated Schering's patent rights by submitting to the U.S. Food and Drug...
To view the full article, register now.